jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Back Swelling - Large Biopsy 3-6 cm

Biopsy
image

Report in 288Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Biopsy of a large swelling in the back for histopathology.

₹666₹951

30% OFF

Back Swelling - Large Biopsy 3-6 cm

  • Why is it done?
    • Tissue diagnosis and microscopic examination of palpable back masses measuring 3-6 cm in diameter
    • Determine if a back lesion or swelling is benign or malignant
    • Identify specific pathology including lipomas, cysts, fibromas, melanomas, or other soft tissue tumors
    • Evaluate swellings that have changed in size, shape, or appearance
    • Guide treatment planning and determine prognosis for detected lesions
    • Typically performed when imaging studies are inconclusive or when tissue-level diagnosis is required for clinical decision-making
  • Normal Range
    • Normal Result: Benign tissue composition (lipoma, epidermoid cyst, fibromas, hemangioma, or other non-cancerous lesions)
    • Abnormal Result: Malignant findings (melanoma, squamous cell carcinoma, basal cell carcinoma, sarcoma, or other cancerous lesions)
    • Size Parameter: Lesion diameter of 3-6 centimeters (large biopsy suitable for complete excisional or substantial incisional sampling)
    • Interpretation of Findings: Negative for malignancy indicates benign pathology; Positive for malignancy requires staging and oncological intervention
  • Interpretation
    • Benign Pathology: Lipomas, epidermoid cysts, fibromas, hemangiomas, and dermatofibromas are non-threatening lesions requiring reassurance and monitoring; no further treatment usually necessary unless cosmetically concerning
    • Melanoma (Malignant): Requires complete staging (CT, MRI, sentinel lymph node biopsy) and surgical excision with appropriate margins based on Breslow thickness and Clark level
    • Squamous Cell Carcinoma: Grade differentiation (well, moderately, or poorly differentiated) affects prognosis; requires surgical excision with margins and assessment for lymph node involvement
    • Basal Cell Carcinoma: Lowest metastatic potential but still requires complete surgical removal with adequate margins to prevent recurrence
    • Sarcoma (Soft Tissue): Grading and histologic type determine aggressiveness; requires multimodal treatment including surgery, radiation, and possible chemotherapy
    • Factors Affecting Results: Specimen adequacy, tissue staining quality, pathologist expertise, location on back, sun exposure history, and previous skin conditions may influence interpretation and clinical significance
  • Associated Organs
    • Primary Systems Involved: Integumentary system (skin and soft tissues), skeletal system (underlying muscle and fascia of the back), lymphatic system (regional lymph nodes)
    • Common Associated Conditions: Cutaneous melanoma, non-melanoma skin cancer, soft tissue sarcomas, benign lipomas, dermatologic cysts, fibromas, and hemangiomas
    • Diseases Diagnosed: Melanoma (including nodular and superficial spreading subtypes), squamous cell carcinoma, basal cell carcinoma, malignant peripheral nerve sheath tumors, liposarcoma, and other cutaneous malignancies
    • Potential Complications from Malignancy: Regional lymph node involvement, distant metastasis to lungs/brain/liver, local tissue invasion, nerve compression, and systemic manifestations depending on tumor stage and type
    • Biopsy-Related Risks: Infection, bleeding, hematoma formation, nerve injury, scarring, and rare potential for tumor tract seeding (though minimal with proper technique)
  • Follow-up Tests
    • If Malignancy Confirmed: CT chest/abdomen/pelvis for metastatic staging, MRI brain for melanoma, PET-CT scan for high-risk tumors, sentinel lymph node biopsy, dermatoscopy, and immunohistochemical staining
    • If Benign Pathology Confirmed: Clinical follow-up at 3-6 months for monitoring changes, surveillance skin exams, and documentation of lesion characteristics
    • Complementary Tests: Complete blood count (CBC), lactate dehydrogenase (LDH) level, liver function tests, baseline metabolic panel prior to any adjuvant therapy
    • Long-term Surveillance: For melanoma: clinical exams every 1-3 months initially, imaging every 3-12 months based on stage; for non-melanoma skin cancer: annual skin exams and patient self-examination education
  • Fasting Required?
    • Fasting Required: No
    • Patient Preparation Instructions: Arrive 15 minutes early; wear comfortable clothing allowing easy access to back area; inform physician of all medications and allergies
    • Medications to Avoid: Aspirin (stop 5-7 days prior), non-steroidal anti-inflammatory drugs NSAIDs (stop 5-7 days prior), anticoagulants (discuss with physician regarding timing of continuation or temporary discontinuation)
    • Pre-Procedure Requirements: Clean the biopsy site with soap and water the morning of procedure; do not apply lotions or creams to back area; arrange for transportation if procedure requires sedation
    • Post-Procedure Care: Keep biopsy site clean and dry; change dressing as directed; avoid strenuous activity and heavy lifting for 1-2 weeks; watch for signs of infection; suture removal typically at 10-14 days

How our test process works!

customers
customers